Wellcome funding boost for Bharat and Maryland's Salmonella vaccine
This article was originally published in Scrip
Executive Summary
The University of Maryland School of Medicine's Center for Vaccine Development (CVD) and Bharat Biotech of India have been granted a $4 million strategic translation award from The Wellcome Trust to develop CVD's conjugate vaccine to prevent the potentially lethal infectious disease caused by invasive non-typhoidal Salmonella (NTS).